BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2013
View Archived Issues
Shionogi reveals development highlights of second quarter of fiscal 2013
Read More
Aclaris Therapeutics begins IND-directed program for A-101
Read More
Cells prepared for Nuvilex phase III pancreatic cancer trials
Read More
Armgo Pharma receives grant from Kennedy's Disease Association
Read More
Eisai offers overview of first half of fiscal 2013
Read More
OPKO Health initiates pivotal validation study for 4Kscore test for prostate cancer
Read More
Aposense PET radiotracer may identify high-risk atherosclerotic plaques
Read More
Novel B-raf inhibitor as a potential treatment for BRAF mutant cancers
Read More
[18F]LMI-1195 PET demonstrates potential for oncological indications
Read More
Substrate allows imaging of amino acid transporter ATB0+ overexpressing tumors
Read More
New model of familial dysautonomia allows testing of therapeutic strategies
Read More
Researchers in the U.S. patent novel neuroprotective oligopeptides
Read More
Gilead Sciences synthesizes new agents for HIV infection
Read More
Immunocore advances IMCgp-100 to phase IIa
Read More
Japanese group presents new FLT3 inhibitors for leukemia
Read More
Bayer Healthcare submits MAA in Europe for Eylea in DME
Read More
Researchers at Allergan prepare novel FPR2 modulators
Read More
HerpV vaccine meets primary endpoint in phase II study for genital herpes
Read More
French and U.S. team synthesize novel RyR1/RyR2 modulators
Read More
Health Canada approves Giotrif
Read More
CFI-400945 as a potent and selective first-in-class PLK-4 inhibitor for the treatment of cancer
Read More
NIBIO, Aeras and Create Vaccine sign basic agreement to develop TB vaccines
Read More
BioCryst begins dosing in phase IIa study of BCX-4161 for hereditary angioedema
Read More
Committee recommends discontinuation of phase II trial of TSO in Crohn's disease
Read More
Evotec and Johnson & Johnson Innovation establish collaboration in Alzheimer's disease
Read More